# Evaluation of the Effect of Genetic Polymorphisms in ERCC1 and OCT2 on the Occurrence and Severity of Cisplatin-induced Nephrotoxicity

> **NCT05247671** · — · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 89 (estimated)

## Conditions studied

- Cisplatin Adverse Reaction

## Interventions

- **GENETIC:** ERCC1
- **GENETIC:** OCT2

## Key facts

- **NCT ID:** NCT05247671
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-15
- **Primary completion:** 2022-08-15
- **Final completion:** 2022-12-15
- **Target enrollment:** 89 (ESTIMATED)
- **Last updated:** 2022-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05247671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05247671, "Evaluation of the Effect of Genetic Polymorphisms in ERCC1 and OCT2 on the Occurrence and Severity of Cisplatin-induced Nephrotoxicity". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05247671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*